Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care

Trial Profile

Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2012

At a glance

  • Drugs Thrombomodulin alfa (Primary)
  • Indications Disseminated intravascular coagulation; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top